AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity
- PMID: 19262508
- PMCID: PMC3616311
- DOI: 10.1038/nature07813
AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity
Abstract
AMP-activated protein kinase (AMPK) is a metabolic fuel gauge conserved along the evolutionary scale in eukaryotes that senses changes in the intracellular AMP/ATP ratio. Recent evidence indicated an important role for AMPK in the therapeutic benefits of metformin, thiazolidinediones and exercise, which form the cornerstones of the clinical management of type 2 diabetes and associated metabolic disorders. In general, activation of AMPK acts to maintain cellular energy stores, switching on catabolic pathways that produce ATP, mostly by enhancing oxidative metabolism and mitochondrial biogenesis, while switching off anabolic pathways that consume ATP. This regulation can take place acutely, through the regulation of fast post-translational events, but also by transcriptionally reprogramming the cell to meet energetic needs. Here we demonstrate that AMPK controls the expression of genes involved in energy metabolism in mouse skeletal muscle by acting in coordination with another metabolic sensor, the NAD+-dependent type III deacetylase SIRT1. AMPK enhances SIRT1 activity by increasing cellular NAD+ levels, resulting in the deacetylation and modulation of the activity of downstream SIRT1 targets that include the peroxisome proliferator-activated receptor-gamma coactivator 1alpha and the forkhead box O1 (FOXO1) and O3 (FOXO3a) transcription factors. The AMPK-induced SIRT1-mediated deacetylation of these targets explains many of the convergent biological effects of AMPK and SIRT1 on energy metabolism.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3616311/bin/emss-52526-f0002.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3616311/bin/emss-52526-f0003.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3616311/bin/emss-52526-f0004.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3616311/bin/emss-52526-f0005.gif)
Similar articles
-
Leucine supplementation increases SIRT1 expression and prevents mitochondrial dysfunction and metabolic disorders in high-fat diet-induced obese mice.Am J Physiol Endocrinol Metab. 2012 Nov 15;303(10):E1234-44. doi: 10.1152/ajpendo.00198.2012. Epub 2012 Sep 11. Am J Physiol Endocrinol Metab. 2012. PMID: 22967499 Free PMC article.
-
Short-term adenosine monophosphate-activated protein kinase activator 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside treatment increases the sirtuin 1 protein expression in skeletal muscle.Metabolism. 2011 Mar;60(3):394-403. doi: 10.1016/j.metabol.2010.03.003. Epub 2010 Apr 1. Metabolism. 2011. PMID: 20362304
-
Interdependence of AMPK and SIRT1 for metabolic adaptation to fasting and exercise in skeletal muscle.Cell Metab. 2010 Mar 3;11(3):213-9. doi: 10.1016/j.cmet.2010.02.006. Cell Metab. 2010. PMID: 20197054 Free PMC article.
-
Metabolic benefits from Sirt1 and Sirt1 activators.Curr Opin Clin Nutr Metab Care. 2009 Jul;12(4):431-7. doi: 10.1097/MCO.0b013e32832cdaae. Curr Opin Clin Nutr Metab Care. 2009. PMID: 19474719 Review.
-
PGC-1alpha, SIRT1 and AMPK, an energy sensing network that controls energy expenditure.Curr Opin Lipidol. 2009 Apr;20(2):98-105. doi: 10.1097/MOL.0b013e328328d0a4. Curr Opin Lipidol. 2009. PMID: 19276888 Free PMC article. Review.
Cited by
-
Potential application of traditional Chinese medicine in age-related macular degeneration-focusing on mitophagy.Front Pharmacol. 2024 May 17;15:1410998. doi: 10.3389/fphar.2024.1410998. eCollection 2024. Front Pharmacol. 2024. PMID: 38828456 Free PMC article. Review.
-
Mitochondrial quality control in human health and disease.Mil Med Res. 2024 May 29;11(1):32. doi: 10.1186/s40779-024-00536-5. Mil Med Res. 2024. PMID: 38812059 Free PMC article. Review.
-
Time of exercise differentially impacts bone growth in mice.Nat Metab. 2024 Jun;6(6):1036-1052. doi: 10.1038/s42255-024-01057-0. Epub 2024 May 28. Nat Metab. 2024. PMID: 38806654
-
Early Life Programming of Adipose Tissue Remodeling and Browning Capacity by Micronutrients and Bioactive Compounds as a Potential Anti-Obesity Strategy.Cells. 2024 May 18;13(10):870. doi: 10.3390/cells13100870. Cells. 2024. PMID: 38786092 Free PMC article. Review.
-
Clostridium butyricum upregulates GPR109A/AMPK/PGC-1α and ameliorates acute pancreatitis-associated intestinal barrier injury in mice.Arch Microbiol. 2024 May 18;206(6):265. doi: 10.1007/s00203-024-04001-8. Arch Microbiol. 2024. PMID: 38761195
References
REFERENCE LIST
-
- Hardie DG. AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy. Nat Rev Mol Cell Biol. 2007;8:774–85. - PubMed
-
- Fryer LG, Parbu-Patel A, Carling D. The Anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways. J Biol Chem. 2002;277:25226–32. - PubMed
-
- Barnes BR, et al. Changes in exercise-induced gene expression in 5′-AMP-activated protein kinase gamma3-null and gamma3 R225Q transgenic mice. Diabetes. 2005;54:3484–9. - PubMed
REFERENCES FOR THE SUPPLEMENTAL PROCEDURES
-
- Rodgers JT, et al. Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature. 2005;434:113–8. - PubMed
-
- Huss JM, Kopp RP, Kelly DP. Peroxisome proliferator-activated receptor coactivator-1alpha (PGC-1alpha) coactivates the cardiac-enriched nuclear receptors estrogen-related receptor-alpha and -gamma. Identification of novel leucine-rich interaction motif within PGC-1alpha. J Biol Chem. 2002;277:40265–74. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous